BELLEVILLE, ON, April 3, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that Institutional Shareholder Services (ISS) has recommended that shareholders vote FOR the special resolution pertaining to the sale of all of the Corporation's Animal Health business to Vétoquinol SA, to be considered at the upcoming Special Meeting of Shareholders: Monday, April 14, 2014 9:00 .m. EST Norton Rose Fulbright Canada Board Rooms D, E, and F Royal Bank Plaza, South Tower, Suite 3800 200 Bay Street Toronto, Ontario ISS is an independent proxy advisory firm that, among other services, provides proxy voting recommendations to pension funds, investment managers, mutual funds, and other institutional shareholders. In its analysis, ISS said: "The asset sale transaction makes strategic sense as it enables the company to realize value for some of the assets. While market reaction is negative, the price is a premium of $0.10 to the share price on the unaffected day (30%).